XBITNasdaqPharmaceutical PreparationsFiscal year ends December 31
XBiotech Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$2.00−0.12 (-5.66%)
Close on Oct 19, 2026
- Market cap
- $60.98M
- P/E (TTM)
- –
- Dividend yield
- –
Earnings
Quarterly results announced on Form 8-K, Item 2.02
| Quarter | Reported | Time | Revenue | EPS (GAAP) | EPS (adjusted) |
|---|---|---|---|---|---|
| Q2 FY2015 Ended Jun 30, 2015 | Jul 29, 2015 | During market hours | – | – | – |
Press releases
Announcements XBiotech filed with the SEC
XBiotech to Begin Constructing New R&D Facility on its 48-acre
Material agreement · New financial obligation · Unregistered share sale · Other events · EX-99.1 to Form 8-K
XBiotech Announces Dividend to Holders of Common Stock
Other events · EX-99.1 to Form 8-K